Last deal

$19.7M
Local Amount - JPY 2.8B

Amount

Series B

Stage

28.03.2022

Date

3

all rounds

$70.5M

Total amount

General

About Company
Aculys Pharma is a pharmaceutical company that develops innovative medical methods for patients.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Aculys

founded date

01.01.2021

Number of employees

Last funding type

Series B

IPO status

Private

Description

The company specializes in creating therapeutic medicines that aim to cure hypersomnia and other debilitating neurologic diseases. Aculys Pharma focuses on central nervous system (CNS) treatment and aims to improve the quality of life for patients in Japan. Their goal is to provide superior medical methods to patients through their innovative drug development.
Contacts